一名患有骨髓增生异常综合征且依赖血液透析的终末期肾病患者成功进行了异基因干细胞移植。 - Suppr | 超能文献

Successful allogeneic stem-cell transplantation in a patient with myelodysplastic syndrome with hemodialysis-dependent end-stage renal disease.

作者信息

Choi Hong Seok, Kim Sung-Yong, Lee Jong-Ho, Yoon So Young, Cho Yo-Han, Lee Hong Ghi

出版信息

Transplantation. 2011 Sep 27;92(6):e28-9. doi: 10.1097/TP.0b013e31822a79f1.

DOI:10.1097/TP.0b013e31822a79f1

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Successful allogeneic stem-cell transplantation in a patient with myelodysplastic syndrome with hemodialysis-dependent end-stage renal disease.一名患有骨髓增生异常综合征且依赖血液透析的终末期肾病患者成功进行了异基因干细胞移植。

Transplantation. 2011 Sep 27;92(6):e28-9. doi: 10.1097/TP.0b013e31822a79f1.

2

Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?低甲基化剂能否为骨髓增生异常综合征的治愈疗法提供平台？

Best Pract Res Clin Haematol. 2012 Dec;25(4):443-51. doi: 10.1016/j.beha.2012.10.007. Epub 2012 Oct 25.

3

Successful treatment of relapsed AML after allogeneic stem cell transplantation with azacitidine.使用阿扎胞苷成功治疗异基因干细胞移植后复发的急性髓系白血病。

Leuk Res. 2007 Feb;31(2):257-9. doi: 10.1016/j.leukres.2006.03.003. Epub 2006 Apr 18.

4

Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens.接受减低强度预处理方案的骨髓增生异常综合征患者的移植前低甲基化药物治疗

Biol Blood Marrow Transplant. 2014 Sep;20(9):1260-1. doi: 10.1016/j.bbmt.2014.07.006. Epub 2014 Jul 11.

5

Azacitidine in the treatment of pediatric therapy-related myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.阿扎胞苷治疗异基因造血干细胞移植后儿童治疗相关骨髓增生异常综合征

J Pediatr Hematol Oncol. 2014 Jul;36(5):e322-4. doi: 10.1097/MPH.0000000000000042.

6

[Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk myelodysplastic syndrome].异基因造血干细胞移植治疗高危骨髓增生异常综合征

Rinsho Ketsueki. 2014 Oct;55(10):1870-81.

7

Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent.在1例接受阿扎胞苷及同时使用1α-25-二羟基维生素D3作为分化剂治疗的高危骨髓增生异常综合征患者中进行的非亲缘骨髓移植。

Leuk Res. 2007 Sep;31(9):1321-3. doi: 10.1016/j.leukres.2006.10.006. Epub 2006 Nov 20.

8

Transplantation for MDS in the elderly: more evidence, or more bias?老年骨髓增生异常综合征的移植治疗：更多证据，还是更多偏差？

Biol Blood Marrow Transplant. 2012 Sep;18(9):1320-1. doi: 10.1016/j.bbmt.2012.06.009. Epub 2012 Jun 29.

9

Durable complete remission after single agent decitabine in AML relapsing in extramedullary sites after allo-SCT.异基因造血干细胞移植后髓外复发的急性髓系白血病患者接受单药地西他滨治疗后获得持久完全缓解。

Bone Marrow Transplant. 2012 Jul;47(7):1008-9. doi: 10.1038/bmt.2011.210. Epub 2011 Nov 14.

10

Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older MDS/AML patients.在接受异基因血液 SCT 之前，对老年 MDS/AML 患者进行低剂量 5-氮杂-2'-脱氧胞苷（DAC）的非强化治疗。

Bone Marrow Transplant. 2009 Nov;44(9):585-8. doi: 10.1038/bmt.2009.64. Epub 2009 Apr 13.

引用本文的文献

1

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).采用移植后环磷酰胺的单倍体相合异基因干细胞移植及后续肾移植治疗终末期肾病（ESKD）的重症镰状细胞病患者。

Bone Marrow Transplant. 2023 Jul;58(7):835-838. doi: 10.1038/s41409-023-01981-x. Epub 2023 Apr 12.

2

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.移植前肾功能不全对异基因造血细胞移植后结局的影响。

Transplant Cell Ther. 2021 May;27(5):410-422. doi: 10.1016/j.jtct.2021.02.030. Epub 2021 Feb 26.